Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Business

A flagging U.S. industry looks for new life in a Philadelphia shipyard

by admin July 19, 2025
July 19, 2025
A flagging U.S. industry looks for new life in a Philadelphia shipyard

The U.S. shipbuilding industry is looking for help. A South Korean company is answering the call.

Hanwha Philly Shipyard CEO David Kim, nodding to the gargantuan vessels under construction just off the Delaware River, on Wednesday offered the kind of vision that has brought some optimism back to the U.S. shipbuilding community.

“You take that level of experience, the technology that we have, the know-how, the process expertise, and so clearly, we believe we have a lot to bring to the Philly Shipyard, as well as to the U.S. maritime industrial base, in terms of modernization capacity,” he said on a walkthrough of the shipyard.

Hanwha Philly Shipyard CEO David Kim.Obtained by NBC News

Hanwha Group bought the Philly Shipyard in December for $100 million and plans to invest multiple times that amount in the yard, training over a thousand new workers and bringing in new high-tech equipment. The company hopes to build naval ships and become the first U.S. builder of specialized liquefied natural gas tankers.

Shipbuilding in the United States has been all but dormant. China, South Korea, Japan and Europe all produce far more ships than the United States, with the few shipyards still operating in the country concentrating on military ships.

Revitalizing shipbuilding has been one of the areas President Donald Trump has pointed to as part of a broader effort to bring manufacturing back to the United States — a move some see as shortsighted considering the costs associated with building the kind of gigantic modern ships that remain a core part of how goods and commodities move around the planet.

This post appeared first on NBC NEWS

previous post
PETA applauds GOP lawmakers’ demand to halt NIH funding for ‘cruel’ overseas animal testing
next post
Coca-Cola dodges after Trump says soda will switch back to cane sugar

Related Posts

PepsiCo buys prebiotic soda brand Poppi for nearly...

March 18, 2025

Trump signs executive order to end collective bargaining...

March 29, 2025

How UnitedHealthcare became the face of America’s health...

May 23, 2025

Hasbro forecasts as much as $300 million impact...

April 26, 2025

Plummeting stock, boycotts and flagging sales: What’s fueling turmoil for Tesla?

March 18, 2025

Kenvue stock drops 10% on report RFK Jr....

September 8, 2025

Coca-Cola takes on Olipop and Poppi with new...

February 20, 2025

Warner Bros. Discovery rejects Paramount’s amended takeover offer

January 11, 2026

Uber will let women drivers and riders request...

July 25, 2025

Playboy moving its headquarters to Miami Beach and...

August 17, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved